Child Neurology: Infantile Biotin Thiamine Responsive Basal Ganglia Disease
Authors:
Open Access
- 25 April 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (17) , 836-839
Abstract
Biotin thiamine responsive basal ganglia disease (BTRBGD) is an inherited autosomal recessive disorder that results from the inability of thiamine to cross the blood brain barrier.1-3 It is considered a treatable condition if vitamin supplementation, most commonly with thiamine and biotin, is initiated early.2 BTRBGD can present as an infantile form, classical childhood form, or adult Wernicke-like encephalopathy.3 The infantile form is often the most severe and portends a worse prognosis with high mortality despite vitamin supplementation. We present a two-month-old who presented with irritability, opisthotonos, and abnormal eye movements who was found to have compound heterozygous variants in the SLC19A3 gene inherited in trans, including one known pathogenic intronic variant and a novel variant presumed to be pathogenic. She was therefore diagnosed with infantile BTRBGD. In this report, we discuss the differential for infantile BTRBGD, the clinical and radiologic features of BTRBGD, and describe a rapid, positive response to early vitamin supplementation in an infant with a likely pathogenic novel variant in SLC19A3.Keywords
This publication has 15 references indexed in Scilit:
- Thiamine deficiency in childhood with attention to genetic causes: Survival and outcome predictorsAnnals of Neurology, 2017
- Biotin‐thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next‐generation sequencing dataAmerican Journal of Medical Genetics Part A, 2017
- Treatable Inborn Errors of Metabolism Due to Membrane Vitamin Transporters DeficiencySeminars in Pediatric Neurology, 2016
- Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine aloneEuropean Journal of Paediatric Neurology, 2015
- Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable diseaseBrain, 2014
- Reversible Lactic Acidosis in a Newborn With Thiamine Transporter-2 DeficiencyPediatrics, 2013
- Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathyBrain, 2013
- Biotin-responsive basal ganglia disease revisitedNeurology, 2013
- Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new casesOrphanet Journal of Rare Diseases, 2013
- Aberrant 5′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilizationNucleic Acids Research, 2007